Medicare Part D and GLP-1 drugs in the United States
How many Medicare drug plans sold in the United States list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in the United States that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 175 of 5,496 (3.2%) | 5,492 of 5,492 (100%) | 5,492 of 5,492 |
| Zepbound | 26 of 5,496 (0.5%) | 7 of 5,492 (0.1%) | 7 of 7 |
| Ozempic | 5,445 of 5,496 (99.1%) | 5,492 of 5,492 (100%) | 5,492 of 5,492 |
| Mounjaro | 5,343 of 5,496 (97.2%) | 5,327 of 5,492 (97.0%) | 5,327 of 5,327 |
| Foundayo | 0 of 5,496 (0%) | 0 of 5,492 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Alabama
How many Medicare drug plans sold in Alabama list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Alabama that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 102 (0%) | 115 of 115 (100%) | 115 of 115 |
| Zepbound | 0 of 102 (0%) | 0 of 115 (0%) | – |
| Ozempic | 102 of 102 (100%) | 115 of 115 (100%) | 115 of 115 |
| Mounjaro | 102 of 102 (100%) | 115 of 115 (100%) | 115 of 115 |
| Foundayo | 0 of 102 (0%) | 0 of 115 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Alaska
How many Medicare drug plans sold in Alaska list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Alaska that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 9 (0%) | 9 of 9 (100%) | 9 of 9 |
| Zepbound | 0 of 9 (0%) | 0 of 9 (0%) | – |
| Ozempic | 9 of 9 (100%) | 9 of 9 (100%) | 9 of 9 |
| Mounjaro | 9 of 9 (100%) | 9 of 9 (100%) | 9 of 9 |
| Foundayo | 0 of 9 (0%) | 0 of 9 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Arizona
How many Medicare drug plans sold in Arizona list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Arizona that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 136 (0%) | 148 of 148 (100%) | 148 of 148 |
| Zepbound | 0 of 136 (0%) | 0 of 148 (0%) | – |
| Ozempic | 136 of 136 (100%) | 148 of 148 (100%) | 148 of 148 |
| Mounjaro | 136 of 136 (100%) | 148 of 148 (100%) | 148 of 148 |
| Foundayo | 0 of 136 (0%) | 0 of 148 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Arkansas
How many Medicare drug plans sold in Arkansas list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Arkansas that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 93 (0%) | 86 of 86 (100%) | 86 of 86 |
| Zepbound | 0 of 93 (0%) | 0 of 86 (0%) | – |
| Ozempic | 93 of 93 (100%) | 86 of 86 (100%) | 86 of 86 |
| Mounjaro | 93 of 93 (100%) | 86 of 86 (100%) | 86 of 86 |
| Foundayo | 0 of 93 (0%) | 0 of 86 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in California
How many Medicare drug plans sold in California list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in California that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 52 of 397 (13.1%) | 397 of 397 (100%) | 397 of 397 |
| Zepbound | 3 of 397 (0.8%) | 1 of 397 (0.3%) | 1 of 1 |
| Ozempic | 397 of 397 (100%) | 397 of 397 (100%) | 397 of 397 |
| Mounjaro | 349 of 397 (87.9%) | 344 of 397 (86.6%) | 344 of 344 |
| Foundayo | 0 of 397 (0%) | 0 of 397 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Colorado
How many Medicare drug plans sold in Colorado list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Colorado that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 14 of 106 (13.2%) | 106 of 106 (100%) | 106 of 106 |
| Zepbound | 0 of 106 (0%) | 0 of 106 (0%) | – |
| Ozempic | 100 of 106 (94.3%) | 106 of 106 (100%) | 106 of 106 |
| Mounjaro | 92 of 106 (86.8%) | 95 of 106 (89.6%) | 95 of 95 |
| Foundayo | 0 of 106 (0%) | 0 of 106 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Connecticut
How many Medicare drug plans sold in Connecticut list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Connecticut that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 53 (0%) | 54 of 54 (100%) | 54 of 54 |
| Zepbound | 0 of 53 (0%) | 0 of 54 (0%) | – |
| Ozempic | 53 of 53 (100%) | 54 of 54 (100%) | 54 of 54 |
| Mounjaro | 53 of 53 (100%) | 54 of 54 (100%) | 54 of 54 |
| Foundayo | 0 of 53 (0%) | 0 of 54 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Delaware
How many Medicare drug plans sold in Delaware list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Delaware that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 2 of 42 (4.8%) | 43 of 43 (100%) | 43 of 43 |
| Zepbound | 2 of 42 (4.8%) | 0 of 43 (0%) | – |
| Ozempic | 42 of 42 (100%) | 43 of 43 (100%) | 43 of 43 |
| Mounjaro | 40 of 42 (95.2%) | 43 of 43 (100%) | 43 of 43 |
| Foundayo | 0 of 42 (0%) | 0 of 43 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in District of Columbia
How many Medicare drug plans sold in District of Columbia list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in District of Columbia that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 3 of 25 (12.0%) | 21 of 21 (100%) | 21 of 21 |
| Zepbound | 0 of 25 (0%) | 0 of 21 (0%) | – |
| Ozempic | 25 of 25 (100%) | 21 of 21 (100%) | 21 of 21 |
| Mounjaro | 22 of 25 (88.0%) | 17 of 21 (81.0%) | 17 of 17 |
| Foundayo | 0 of 25 (0%) | 0 of 21 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Florida
How many Medicare drug plans sold in Florida list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Florida that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 11 of 597 (1.8%) | 549 of 549 (100%) | 549 of 549 |
| Zepbound | 11 of 597 (1.8%) | 6 of 549 (1.1%) | 6 of 6 |
| Ozempic | 595 of 597 (99.7%) | 549 of 549 (100%) | 549 of 549 |
| Mounjaro | 594 of 597 (99.5%) | 531 of 549 (96.7%) | 531 of 531 |
| Foundayo | 0 of 597 (0%) | 0 of 549 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Georgia
How many Medicare drug plans sold in Georgia list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Georgia that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 8 of 154 (5.2%) | 151 of 151 (100%) | 151 of 151 |
| Zepbound | 0 of 154 (0%) | 0 of 151 (0%) | – |
| Ozempic | 154 of 154 (100%) | 151 of 151 (100%) | 151 of 151 |
| Mounjaro | 146 of 154 (94.8%) | 143 of 151 (94.7%) | 143 of 143 |
| Foundayo | 0 of 154 (0%) | 0 of 151 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Hawaii
How many Medicare drug plans sold in Hawaii list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Hawaii that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 6 of 46 (13.0%) | 50 of 50 (100%) | 50 of 50 |
| Zepbound | 0 of 46 (0%) | 0 of 50 (0%) | – |
| Ozempic | 46 of 46 (100%) | 50 of 50 (100%) | 50 of 50 |
| Mounjaro | 40 of 46 (87.0%) | 44 of 50 (88.0%) | 44 of 44 |
| Foundayo | 0 of 46 (0%) | 0 of 50 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Idaho
How many Medicare drug plans sold in Idaho list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Idaho that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 50 (0%) | 45 of 45 (100%) | 45 of 45 |
| Zepbound | 0 of 50 (0%) | 0 of 45 (0%) | – |
| Ozempic | 50 of 50 (100%) | 45 of 45 (100%) | 45 of 45 |
| Mounjaro | 50 of 50 (100%) | 45 of 45 (100%) | 45 of 45 |
| Foundayo | 0 of 50 (0%) | 0 of 45 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Illinois
How many Medicare drug plans sold in Illinois list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Illinois that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 150 (0%) | 133 of 133 (100%) | 133 of 133 |
| Zepbound | 0 of 150 (0%) | 0 of 133 (0%) | – |
| Ozempic | 150 of 150 (100%) | 133 of 133 (100%) | 133 of 133 |
| Mounjaro | 150 of 150 (100%) | 133 of 133 (100%) | 133 of 133 |
| Foundayo | 0 of 150 (0%) | 0 of 133 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Indiana
How many Medicare drug plans sold in Indiana list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Indiana that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 128 (0%) | 140 of 140 (100%) | 140 of 140 |
| Zepbound | 0 of 128 (0%) | 0 of 140 (0%) | – |
| Ozempic | 128 of 128 (100%) | 140 of 140 (100%) | 140 of 140 |
| Mounjaro | 128 of 128 (100%) | 140 of 140 (100%) | 140 of 140 |
| Foundayo | 0 of 128 (0%) | 0 of 140 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Iowa
How many Medicare drug plans sold in Iowa list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Iowa that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 65 (0%) | 64 of 64 (100%) | 64 of 64 |
| Zepbound | 0 of 65 (0%) | 0 of 64 (0%) | – |
| Ozempic | 61 of 65 (93.8%) | 64 of 64 (100%) | 64 of 64 |
| Mounjaro | 64 of 65 (98.5%) | 63 of 64 (98.4%) | 63 of 63 |
| Foundayo | 0 of 65 (0%) | 0 of 64 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Kansas
How many Medicare drug plans sold in Kansas list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Kansas that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 89 (0%) | 84 of 84 (100%) | 84 of 84 |
| Zepbound | 0 of 89 (0%) | 0 of 84 (0%) | – |
| Ozempic | 89 of 89 (100%) | 84 of 84 (100%) | 84 of 84 |
| Mounjaro | 89 of 89 (100%) | 84 of 84 (100%) | 84 of 84 |
| Foundayo | 0 of 89 (0%) | 0 of 84 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Kentucky
How many Medicare drug plans sold in Kentucky list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Kentucky that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 115 (0%) | 123 of 123 (100%) | 123 of 123 |
| Zepbound | 0 of 115 (0%) | 0 of 123 (0%) | – |
| Ozempic | 115 of 115 (100%) | 123 of 123 (100%) | 123 of 123 |
| Mounjaro | 115 of 115 (100%) | 123 of 123 (100%) | 123 of 123 |
| Foundayo | 0 of 115 (0%) | 0 of 123 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Louisiana
How many Medicare drug plans sold in Louisiana list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Louisiana that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 1 of 114 (0.9%) | 126 of 126 (100%) | 126 of 126 |
| Zepbound | 1 of 114 (0.9%) | 0 of 126 (0%) | – |
| Ozempic | 114 of 114 (100%) | 126 of 126 (100%) | 126 of 126 |
| Mounjaro | 113 of 114 (99.1%) | 126 of 126 (100%) | 126 of 126 |
| Foundayo | 0 of 114 (0%) | 0 of 126 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Maine
How many Medicare drug plans sold in Maine list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Maine that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 54 (0%) | 52 of 52 (100%) | 52 of 52 |
| Zepbound | 0 of 54 (0%) | 0 of 52 (0%) | – |
| Ozempic | 54 of 54 (100%) | 52 of 52 (100%) | 52 of 52 |
| Mounjaro | 54 of 54 (100%) | 52 of 52 (100%) | 52 of 52 |
| Foundayo | 0 of 54 (0%) | 0 of 52 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Maryland
How many Medicare drug plans sold in Maryland list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Maryland that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 10 of 63 (15.9%) | 49 of 49 (100%) | 49 of 49 |
| Zepbound | 0 of 63 (0%) | 0 of 49 (0%) | – |
| Ozempic | 63 of 63 (100%) | 49 of 49 (100%) | 49 of 49 |
| Mounjaro | 53 of 63 (84.1%) | 37 of 49 (75.5%) | 37 of 37 |
| Foundayo | 0 of 63 (0%) | 0 of 49 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Massachusetts
How many Medicare drug plans sold in Massachusetts list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Massachusetts that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 8 of 96 (8.3%) | 89 of 89 (100%) | 89 of 89 |
| Zepbound | 0 of 96 (0%) | 0 of 89 (0%) | – |
| Ozempic | 96 of 96 (100%) | 89 of 89 (100%) | 89 of 89 |
| Mounjaro | 95 of 96 (99.0%) | 89 of 89 (100%) | 89 of 89 |
| Foundayo | 0 of 96 (0%) | 0 of 89 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Michigan
How many Medicare drug plans sold in Michigan list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Michigan that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 1 of 190 (0.5%) | 183 of 183 (100%) | 183 of 183 |
| Zepbound | 1 of 190 (0.5%) | 0 of 183 (0%) | – |
| Ozempic | 178 of 190 (93.7%) | 183 of 183 (100%) | 183 of 183 |
| Mounjaro | 189 of 190 (99.5%) | 183 of 183 (100%) | 183 of 183 |
| Foundayo | 0 of 190 (0%) | 0 of 183 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Minnesota
How many Medicare drug plans sold in Minnesota list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Minnesota that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 2 of 80 (2.5%) | 63 of 63 (100%) | 63 of 63 |
| Zepbound | 2 of 80 (2.5%) | 0 of 63 (0%) | – |
| Ozempic | 76 of 80 (95.0%) | 63 of 63 (100%) | 63 of 63 |
| Mounjaro | 80 of 80 (100%) | 58 of 63 (92.1%) | 58 of 58 |
| Foundayo | 0 of 80 (0%) | 0 of 63 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Mississippi
How many Medicare drug plans sold in Mississippi list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Mississippi that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 96 (0%) | 105 of 105 (100%) | 105 of 105 |
| Zepbound | 0 of 96 (0%) | 0 of 105 (0%) | – |
| Ozempic | 95 of 96 (99.0%) | 105 of 105 (100%) | 105 of 105 |
| Mounjaro | 96 of 96 (100%) | 105 of 105 (100%) | 105 of 105 |
| Foundayo | 0 of 96 (0%) | 0 of 105 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Missouri
How many Medicare drug plans sold in Missouri list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Missouri that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 155 (0%) | 171 of 171 (100%) | 171 of 171 |
| Zepbound | 0 of 155 (0%) | 0 of 171 (0%) | – |
| Ozempic | 155 of 155 (100%) | 171 of 171 (100%) | 171 of 171 |
| Mounjaro | 155 of 155 (100%) | 171 of 171 (100%) | 171 of 171 |
| Foundayo | 0 of 155 (0%) | 0 of 171 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Montana
How many Medicare drug plans sold in Montana list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Montana that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 36 (0%) | 27 of 27 (100%) | 27 of 27 |
| Zepbound | 0 of 36 (0%) | 0 of 27 (0%) | – |
| Ozempic | 36 of 36 (100%) | 27 of 27 (100%) | 27 of 27 |
| Mounjaro | 36 of 36 (100%) | 26 of 27 (96.3%) | 26 of 26 |
| Foundayo | 0 of 36 (0%) | 0 of 27 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Nebraska
How many Medicare drug plans sold in Nebraska list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Nebraska that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 55 (0%) | 51 of 51 (100%) | 51 of 51 |
| Zepbound | 0 of 55 (0%) | 0 of 51 (0%) | – |
| Ozempic | 55 of 55 (100%) | 51 of 51 (100%) | 51 of 51 |
| Mounjaro | 55 of 55 (100%) | 50 of 51 (98.0%) | 50 of 50 |
| Foundayo | 0 of 55 (0%) | 0 of 51 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Nevada
How many Medicare drug plans sold in Nevada list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Nevada that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 110 (0%) | 100 of 100 (100%) | 100 of 100 |
| Zepbound | 0 of 110 (0%) | 0 of 100 (0%) | – |
| Ozempic | 106 of 110 (96.4%) | 100 of 100 (100%) | 100 of 100 |
| Mounjaro | 110 of 110 (100%) | 97 of 100 (97.0%) | 97 of 97 |
| Foundayo | 0 of 110 (0%) | 0 of 100 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in New Hampshire
How many Medicare drug plans sold in New Hampshire list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in New Hampshire that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 25 (0%) | 25 of 25 (100%) | 25 of 25 |
| Zepbound | 0 of 25 (0%) | 0 of 25 (0%) | – |
| Ozempic | 25 of 25 (100%) | 25 of 25 (100%) | 25 of 25 |
| Mounjaro | 25 of 25 (100%) | 25 of 25 (100%) | 25 of 25 |
| Foundayo | 0 of 25 (0%) | 0 of 25 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in New Jersey
How many Medicare drug plans sold in New Jersey list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in New Jersey that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 85 (0%) | 74 of 74 (100%) | 74 of 74 |
| Zepbound | 0 of 85 (0%) | 0 of 74 (0%) | – |
| Ozempic | 85 of 85 (100%) | 74 of 74 (100%) | 74 of 74 |
| Mounjaro | 85 of 85 (100%) | 73 of 74 (98.6%) | 73 of 73 |
| Foundayo | 0 of 85 (0%) | 0 of 74 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in New Mexico
How many Medicare drug plans sold in New Mexico list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in New Mexico that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 78 (0%) | 68 of 68 (100%) | 68 of 68 |
| Zepbound | 0 of 78 (0%) | 0 of 68 (0%) | – |
| Ozempic | 72 of 78 (92.3%) | 68 of 68 (100%) | 68 of 68 |
| Mounjaro | 78 of 78 (100%) | 68 of 68 (100%) | 68 of 68 |
| Foundayo | 0 of 78 (0%) | 0 of 68 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in New York
How many Medicare drug plans sold in New York list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in New York that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 3 of 202 (1.5%) | 215 of 215 (100%) | 215 of 215 |
| Zepbound | 0 of 202 (0%) | 0 of 215 (0%) | – |
| Ozempic | 202 of 202 (100%) | 215 of 215 (100%) | 215 of 215 |
| Mounjaro | 181 of 202 (89.6%) | 193 of 215 (89.8%) | 193 of 193 |
| Foundayo | 0 of 202 (0%) | 0 of 215 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in North Carolina
How many Medicare drug plans sold in North Carolina list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in North Carolina that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 3 of 173 (1.7%) | 177 of 177 (100%) | 177 of 177 |
| Zepbound | 3 of 173 (1.7%) | 0 of 177 (0%) | – |
| Ozempic | 173 of 173 (100%) | 177 of 177 (100%) | 177 of 177 |
| Mounjaro | 172 of 173 (99.4%) | 177 of 177 (100%) | 177 of 177 |
| Foundayo | 0 of 173 (0%) | 0 of 177 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in North Dakota
How many Medicare drug plans sold in North Dakota list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in North Dakota that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 33 (0%) | 26 of 26 (100%) | 26 of 26 |
| Zepbound | 0 of 33 (0%) | 0 of 26 (0%) | – |
| Ozempic | 33 of 33 (100%) | 26 of 26 (100%) | 26 of 26 |
| Mounjaro | 33 of 33 (100%) | 25 of 26 (96.2%) | 25 of 25 |
| Foundayo | 0 of 33 (0%) | 0 of 26 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Ohio
How many Medicare drug plans sold in Ohio list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Ohio that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 205 (0%) | 173 of 173 (100%) | 173 of 173 |
| Zepbound | 0 of 205 (0%) | 0 of 173 (0%) | – |
| Ozempic | 205 of 205 (100%) | 173 of 173 (100%) | 173 of 173 |
| Mounjaro | 205 of 205 (100%) | 173 of 173 (100%) | 173 of 173 |
| Foundayo | 0 of 205 (0%) | 0 of 173 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Oklahoma
How many Medicare drug plans sold in Oklahoma list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Oklahoma that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 82 (0%) | 81 of 81 (100%) | 81 of 81 |
| Zepbound | 0 of 82 (0%) | 0 of 81 (0%) | – |
| Ozempic | 82 of 82 (100%) | 81 of 81 (100%) | 81 of 81 |
| Mounjaro | 82 of 82 (100%) | 81 of 81 (100%) | 81 of 81 |
| Foundayo | 0 of 82 (0%) | 0 of 81 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Oregon
How many Medicare drug plans sold in Oregon list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Oregon that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 4 of 97 (4.1%) | 92 of 92 (100%) | 92 of 92 |
| Zepbound | 0 of 97 (0%) | 0 of 92 (0%) | – |
| Ozempic | 97 of 97 (100%) | 92 of 92 (100%) | 92 of 92 |
| Mounjaro | 93 of 97 (95.9%) | 88 of 92 (95.7%) | 88 of 88 |
| Foundayo | 0 of 97 (0%) | 0 of 92 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Pennsylvania
How many Medicare drug plans sold in Pennsylvania list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Pennsylvania that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 2 of 319 (0.6%) | 324 of 324 (100%) | 324 of 324 |
| Zepbound | 2 of 319 (0.6%) | 0 of 324 (0%) | – |
| Ozempic | 319 of 319 (100%) | 324 of 324 (100%) | 324 of 324 |
| Mounjaro | 317 of 319 (99.4%) | 324 of 324 (100%) | 324 of 324 |
| Foundayo | 0 of 319 (0%) | 0 of 324 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Rhode Island
How many Medicare drug plans sold in Rhode Island list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Rhode Island that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 31 (0%) | 29 of 29 (100%) | 29 of 29 |
| Zepbound | 0 of 31 (0%) | 0 of 29 (0%) | – |
| Ozempic | 31 of 31 (100%) | 29 of 29 (100%) | 29 of 29 |
| Mounjaro | 31 of 31 (100%) | 29 of 29 (100%) | 29 of 29 |
| Foundayo | 0 of 31 (0%) | 0 of 29 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in South Carolina
How many Medicare drug plans sold in South Carolina list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in South Carolina that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 1 of 93 (1.1%) | 91 of 91 (100%) | 91 of 91 |
| Zepbound | 1 of 93 (1.1%) | 0 of 91 (0%) | – |
| Ozempic | 93 of 93 (100%) | 91 of 91 (100%) | 91 of 91 |
| Mounjaro | 92 of 93 (98.9%) | 91 of 91 (100%) | 91 of 91 |
| Foundayo | 0 of 93 (0%) | 0 of 91 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in South Dakota
How many Medicare drug plans sold in South Dakota list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in South Dakota that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 30 (0%) | 30 of 30 (100%) | 30 of 30 |
| Zepbound | 0 of 30 (0%) | 0 of 30 (0%) | – |
| Ozempic | 30 of 30 (100%) | 30 of 30 (100%) | 30 of 30 |
| Mounjaro | 28 of 30 (93.3%) | 29 of 30 (96.7%) | 29 of 29 |
| Foundayo | 0 of 30 (0%) | 0 of 30 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Tennessee
How many Medicare drug plans sold in Tennessee list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Tennessee that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 135 (0%) | 157 of 157 (100%) | 157 of 157 |
| Zepbound | 0 of 135 (0%) | 0 of 157 (0%) | – |
| Ozempic | 135 of 135 (100%) | 157 of 157 (100%) | 157 of 157 |
| Mounjaro | 135 of 135 (100%) | 157 of 157 (100%) | 157 of 157 |
| Foundayo | 0 of 135 (0%) | 0 of 157 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Texas
How many Medicare drug plans sold in Texas list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Texas that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 407 (0%) | 412 of 412 (100%) | 412 of 412 |
| Zepbound | 0 of 407 (0%) | 0 of 412 (0%) | – |
| Ozempic | 407 of 407 (100%) | 412 of 412 (100%) | 412 of 412 |
| Mounjaro | 407 of 407 (100%) | 412 of 412 (100%) | 412 of 412 |
| Foundayo | 0 of 407 (0%) | 0 of 412 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Utah
How many Medicare drug plans sold in Utah list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Utah that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 58 (0%) | 53 of 53 (100%) | 53 of 53 |
| Zepbound | 0 of 58 (0%) | 0 of 53 (0%) | – |
| Ozempic | 54 of 58 (93.1%) | 53 of 53 (100%) | 53 of 53 |
| Mounjaro | 58 of 58 (100%) | 53 of 53 (100%) | 53 of 53 |
| Foundayo | 0 of 58 (0%) | 0 of 53 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Vermont
How many Medicare drug plans sold in Vermont list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Vermont that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 13 (0%) | 14 of 14 (100%) | 14 of 14 |
| Zepbound | 0 of 13 (0%) | 0 of 14 (0%) | – |
| Ozempic | 13 of 13 (100%) | 14 of 14 (100%) | 14 of 14 |
| Mounjaro | 13 of 13 (100%) | 14 of 14 (100%) | 14 of 14 |
| Foundayo | 0 of 13 (0%) | 0 of 14 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Virginia
How many Medicare drug plans sold in Virginia list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Virginia that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 6 of 138 (4.3%) | 145 of 145 (100%) | 145 of 145 |
| Zepbound | 0 of 138 (0%) | 0 of 145 (0%) | – |
| Ozempic | 138 of 138 (100%) | 145 of 145 (100%) | 145 of 145 |
| Mounjaro | 132 of 138 (95.7%) | 139 of 145 (95.9%) | 139 of 139 |
| Foundayo | 0 of 138 (0%) | 0 of 145 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Washington
How many Medicare drug plans sold in Washington list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Washington that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 19 of 125 (15.2%) | 114 of 114 (100%) | 114 of 114 |
| Zepbound | 0 of 125 (0%) | 0 of 114 (0%) | – |
| Ozempic | 123 of 125 (98.4%) | 114 of 114 (100%) | 114 of 114 |
| Mounjaro | 104 of 125 (83.2%) | 98 of 114 (86.0%) | 98 of 98 |
| Foundayo | 0 of 125 (0%) | 0 of 114 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in West Virginia
How many Medicare drug plans sold in West Virginia list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in West Virginia that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 72 (0%) | 70 of 70 (100%) | 70 of 70 |
| Zepbound | 0 of 72 (0%) | 0 of 70 (0%) | – |
| Ozempic | 72 of 72 (100%) | 70 of 70 (100%) | 70 of 70 |
| Mounjaro | 72 of 72 (100%) | 70 of 70 (100%) | 70 of 70 |
| Foundayo | 0 of 72 (0%) | 0 of 70 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Wisconsin
How many Medicare drug plans sold in Wisconsin list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Wisconsin that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 99 (0%) | 97 of 97 (100%) | 97 of 97 |
| Zepbound | 0 of 99 (0%) | 0 of 97 (0%) | – |
| Ozempic | 89 of 99 (89.9%) | 97 of 97 (100%) | 97 of 97 |
| Mounjaro | 99 of 99 (100%) | 97 of 97 (100%) | 97 of 97 |
| Foundayo | 0 of 99 (0%) | 0 of 97 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Wyoming
How many Medicare drug plans sold in Wyoming list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Wyoming that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 19 (0%) | 13 of 13 (100%) | 13 of 13 |
| Zepbound | 0 of 19 (0%) | 0 of 13 (0%) | – |
| Ozempic | 19 of 19 (100%) | 13 of 13 (100%) | 13 of 13 |
| Mounjaro | 19 of 19 (100%) | 12 of 13 (92.3%) | 12 of 12 |
| Foundayo | 0 of 19 (0%) | 0 of 13 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Puerto Rico
How many Medicare drug plans sold in Puerto Rico list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Puerto Rico that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 22 of 65 (33.8%) | 64 of 64 (100%) | 64 of 64 |
| Zepbound | 0 of 65 (0%) | 0 of 64 (0%) | – |
| Ozempic | 65 of 65 (100%) | 64 of 64 (100%) | 64 of 64 |
| Mounjaro | 65 of 65 (100%) | 64 of 64 (100%) | 64 of 64 |
| Foundayo | 0 of 65 (0%) | 0 of 64 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Virgin Islands
How many Medicare drug plans sold in Virgin Islands list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Virgin Islands that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 1 (0%) | 1 of 1 (100%) | 1 of 1 |
| Zepbound | 0 of 1 (0%) | 0 of 1 (0%) | – |
| Ozempic | 1 of 1 (100%) | 1 of 1 (100%) | 1 of 1 |
| Mounjaro | 1 of 1 (100%) | 1 of 1 (100%) | 1 of 1 |
| Foundayo | 0 of 1 (0%) | 0 of 1 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Guam
How many Medicare drug plans sold in Guam list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Guam that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 1 (0%) | 1 of 1 (100%) | 1 of 1 |
| Zepbound | 0 of 1 (0%) | 0 of 1 (0%) | – |
| Ozempic | 1 of 1 (100%) | 1 of 1 (100%) | 1 of 1 |
| Mounjaro | 1 of 1 (100%) | 1 of 1 (100%) | 1 of 1 |
| Foundayo | 0 of 1 (0%) | 0 of 1 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in American Samoa
How many Medicare drug plans sold in American Samoa list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in American Samoa that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 1 (0%) | 1 of 1 (100%) | 1 of 1 |
| Zepbound | 0 of 1 (0%) | 0 of 1 (0%) | – |
| Ozempic | 1 of 1 (100%) | 1 of 1 (100%) | 1 of 1 |
| Mounjaro | 1 of 1 (100%) | 1 of 1 (100%) | 1 of 1 |
| Foundayo | 0 of 1 (0%) | 0 of 1 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.
Medicare Part D and GLP-1 drugs in Northern Mariana Islands
How many Medicare drug plans sold in Northern Mariana Islands list each GLP-1 drug on their formulary, 2026 and 2027, from CMS's files.
- A known change date has passed since this sheet was built.
Part D plans in Northern Mariana Islands that list each drug[1]
| Drug | 2026 plans | 2027 plans | 2027: with prior authorization |
|---|---|---|---|
| Wegovy | 0 of 1 (0%) | 1 of 1 (100%) | 1 of 1 |
| Zepbound | 0 of 1 (0%) | 0 of 1 (0%) | – |
| Ozempic | 1 of 1 (100%) | 1 of 1 (100%) | 1 of 1 |
| Mounjaro | 1 of 1 (100%) | 1 of 1 (100%) | 1 of 1 |
| Foundayo | 0 of 1 (0%) | 0 of 1 (0%) | – |
Counts are plans, not people. A plan "lists" a drug when its formulary (drug list) includes at least one form or strength.
Part D does not cover GLP-1s for weight loss alone
- Medicare Part D does not cover GLP-1 drugs when they are used for weight loss. CMS's official text:[2]
“If a provider submits a prior authorization request to a Part D plan sponsor for a GLP-1 product that is excluded from coverage under Medicare Part D (agents when used for weight loss) but may be eligible for coverage under the Medicare GLP-1 Bridge, CMS strongly encourages the Part D plan sponsor to assist with directing the claim to the Medicare GLP-1 Bridge for review.”CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors[2] What Part D plans can cover
- Wegovy to lower the risk of heart attack, stroke or death from heart disease in adults with heart disease and obesity or overweight, or for MASH (a fatty liver disease with liver scarring); Zepbound for moderate to severe obstructive sleep apnea in adults with obesity; Ozempic and Mounjaro for type 2 diabetes.[2]
- Most plans that list these drugs require prior authorization (last column): approval from the plan before it covers the drug. Plans can use it to cover a drug for some conditions but not others.[3]
- A plan listing a drug does not mean it will pay for it for a given person. Plans can change their drug lists during the year; check with the plan for its specific coverage rules.[3][4]
For weight management: the Medicare GLP-1 Bridge
- Wegovy, Zepbound KwikPen and Foundayo: a $50 copayment for a one-month supply for people who qualify, outside Part D plans, through December 31, 2027.[5][6]
- To compare plans for one person: Medicare Plan Finder, medicare.gov/plan-compare.
Free help
- Medicare: 1-800-MEDICARE (1-800-633-4227); TTY 1-877-486-2048.[7]
- State Health Insurance Assistance Program (SHIP): free one-on-one Medicare counseling. Find yours at shiphelp.org.[7]
Official sources (date our archive last confirmed each one)
- CMS: Monthly Prescription Drug Plan Formulary and Pharmacy Network Information, plan year 2026 (file 2026_20260916.zip, published 2026-09-23). https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/monthly-prescription-drug-plan-formulary-and-pharmacy-network-information — checked Nov 15, 2026
- CMS: Medicare GLP-1 Bridge FAQs for Part D plan sponsors. https://www.cms.gov/files/document/medicare-glp-1-bridge-expectations-faqs.pdf — checked Nov 15, 2026
- Medicare.gov: Drug plan rules. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules — checked Nov 15, 2026
- Medicare.gov: How do drug plans work?. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/how-drug-plans-work — checked Nov 15, 2026
- Medicare.gov: Weight loss drugs. https://www.medicare.gov/coverage/weight-loss-drugs — checked Nov 15, 2026
- CMS HPMS memo, April 21, 2026. https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf — checked Nov 15, 2026
- Medicare.gov: Talk to someone. https://www.medicare.gov/talk-to-someone — checked Nov 15, 2026
Current version: https://medcostclear.com/data/medicare-part-d-glp1/ · Sheet built Nov 15, 2026. How we keep it current: archived weekly; flagged after 16 days without a check; archived daily; flagged after 7 days without a check.
Not medical or legal advice. MedCost Clear is independent: not affiliated with Medicare, CMS, Social Security or any drug maker, and takes no money from plans, agents or brokers. No ads.